scispace - formally typeset
E

Edward G. Rowan

Researcher at Strathclyde Institute of Pharmacy and Biomedical Sciences

Publications -  121
Citations -  3450

Edward G. Rowan is an academic researcher from Strathclyde Institute of Pharmacy and Biomedical Sciences. The author has contributed to research in topics: Neuromuscular transmission & Acetylcholine. The author has an hindex of 30, co-authored 118 publications receiving 3171 citations. Previous affiliations of Edward G. Rowan include University of Strathclyde.

Papers
More filters
Journal ArticleDOI

On the Convergent Evolution of Animal Toxins CONSERVATION OF A DIAD OF FUNCTIONAL RESIDUES IN POTASSIUM CHANNEL-BLOCKING TOXINS WITH UNRELATED STRUCTURES

TL;DR: Toxins that have unrelated structures but similar functions possess conserved key functional residues, organized in an identical topology, suggesting a convergent functional evolution for these small proteins.
Journal ArticleDOI

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal

TL;DR: In this paper, the late stages of this electrophysiological effect temporally coincide with the loss of heavy neurofilament and type III β-tubulin immunostaining and structural breakdown of the nerve terminal, as demonstrated by electron microscopy.
Journal Article

Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal.

TL;DR: It is shown that the late stages of this electrophysiological effect temporally coincide with the loss of heavy neurofilament and type III beta-tubulin immunostaining and structural breakdown of the nerve terminal, as demonstrated by electron microscopy.
Journal ArticleDOI

Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice

TL;DR: The studies provide a detailed mechanism by which loss of axonal conduction can occur in a distal dominant pattern as observed in a proportion of patients with motor axonal Guillain-Barré syndrome, and also provide an explanation for the occurrence of rapid recovery from complete paralysis and electrophysiological in-excitability.
Journal ArticleDOI

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.

TL;DR: The in vitro sciatic nerve model appears of limited use for analysing electrophysiologically the effects of anti-ganglioside antibodies on nerve function, possibly because its short-term viability and isolation from circulating systemic factors do not permit the evolution of an inflammatory lesion of sufficient magnitude to induce overt electrophYSiological abnormalities.